@Davisite Dr.T I'm a little confusedby this reply as RAC announced 3rd Nov 2021 "Race Initiates University Of Newcastle Collaboration To Develop A Genomics-Based Companion Diagnostic For Zantrene" and 27th Oct 2021 Sheba biomarker collaboration was also announced..
AFAIK there has been no reported outcomes from either of these collaborations.
Is there are reason for this you can share, or can't because of PS or patent being prepared. ?
Are you also suggesting that the planned trials will test for FTO using the biomarkers or diagnostics created from those collaborations ?
Thanks
d.
Pillar 1 - FTO (new thread), page-2873
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.87 |
Change
-0.155(7.67%) |
Mkt cap ! $317.5M | |||
| Open | High | Low | Value | Volume |
| $2.03 | $2.08 | $1.86 | $706.9K | 357.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2637 | $1.87 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.87 | 577 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |